Anson Funds Management LP Gsk PLC Transaction History

Anson Funds Management LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$42.05 - $47.77 $2.31 Million - $2.63 Million	-55,000 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$40.23 - $47.74 $2.21 Million - $2.63 Million	55,000 New	55,000 $2.4 Million
Q4 2021 Feb 14, 2022	SELL	$38.88 - $45.31 $2.33 Million - $2.72 Million	-60,000 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$36.52 - $41.46 $2.19 Million - $2.49 Million	60,000 New	60,000 $2.39 Million
Q1 2020 May 15, 2020	SELL	$32.47 - $48.83 $448,086 - $673,854	-13,800 Closed	0 $0

Q4 2019 Feb 14, 2020	BUY	$42.0 - $48.25 $579,600 - $665,850	13,800 New	13,800 $648,000

175K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $78.3B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Anson Funds Management LP, based on Form 13F filings with the SEC.

Stay updated on Anson Funds Management LP with notifications on news.